Human fecal metabolomic profiling could inform Clostridioides difficile infection diagnosis and treatment
- PMID: 31403467
- PMCID: PMC6715351
- DOI: 10.1172/JCI130008
Human fecal metabolomic profiling could inform Clostridioides difficile infection diagnosis and treatment
Abstract
Clostridioides difficile is a significant public health threat, and diagnosis of this infection is challenging due to a lack of sensitivity in current diagnostic testing. In this issue of the JCI, Robinson et al. use a logistic regression model based on the fecal metabolome that is able to distinguish between patients with non-C. difficile diarrhea and C. difficile infection, and to some degree, patients who are asymptomatically colonized with C. difficile. The authors construct a metabolic definition of human C. difficile infection, which could improve diagnostic accuracy and aid in the development of targeted therapeutics against this pathogen.
Conflict of interest statement
Comment on
-
Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.J Clin Invest. 2019 Aug 12;129(9):3792-3806. doi: 10.1172/JCI126905. eCollection 2019 Aug 12. J Clin Invest. 2019. PMID: 31403473 Free PMC article.
References
-
- McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clin Infect Dis. 2018;66(7):987–994. doi: 10.1093/cid/ciy149. - DOI - PubMed
